Delivery Order SPE2DB22D1017-SPE2DB25FYSAW
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,541.08 for Restasis 0.05% Eye Emulsion (30-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a non-competitive procurement under a larger indefinite delivery contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $12,777.96 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will be completed by July 29, 2025, with work performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,318.51 on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (30 single-use vials). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a small-value transaction issued under a larger indefinite delivery contract vehicle. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units, with a contract ceiling value of $22,836.31. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award selection. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a $3,561.92 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,990.32 to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. The contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery...
- The Defense Logistics Agency awarded a $6,297.40 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Restasis 0.05% eye emulsion (60-unit package). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,110.43 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Restasis 0.05% Eye Emulsion in 30-unit quantities. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive procurement under AmerisourceBergen's existing indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,117.68 on September 26, 2025, for RESTASIS 0.05% Eye Emulsion (60 count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,117.68 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSAWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Restasis 0.05% eye emulsion in 60-count packaging, with a contract ceiling value of $2,658.60. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by September 29, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a minor purchase against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 vehicle designated SPE2DX and running through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company has demonstrated capability across a broad spectrum of pharmaceutical products and medical supplies through multiple competitively awarded contracts with the Defense Logistics Agency. The Restasis delivery order reflects the company's role in providing specialized pharmaceutical commodities to support Department of Defense healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/26/25 |